comparemela.com

Latest Breaking News On - Marketing expenses - Page 9 : comparemela.com

InflaRx N : 11-2023-InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update -November 01, 2023 at 09:13 am EDT

Jena, Germany, November 1, 2023 - InflaRx N.V. , a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today financial results.

United-states
Germany
German
Thomas-taapken
German-ministry-of-education
Development-expenses
Development-of-vilobelimab
Drug-administration
European-medicines-agency
Inflarx-stops-development-of-vilobelimab
European-union
German-ministry-of-health

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
United-states
Munich
Bayern
German
Nielsc-riedemann
Laurie-doyle
Regina-lutz
Thomas-taapken
Katja-arnold
Drug-administration
Inflarx-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.